Immediate Hypersensitivity to Contrast Agents: The French 5-year CIRTACI Study
- PMID: 31193689
- PMCID: PMC6537532
- DOI: 10.1016/j.eclinm.2018.07.002
Immediate Hypersensitivity to Contrast Agents: The French 5-year CIRTACI Study
Abstract
Background: Iodinated and gadolinium-based contrast media (ICM; GBCM) induce immediate hypersensitivity (IH) reactions. Differentiating allergic from non-allergic IH is crucial; allergy contraindicates the culprit agent for life. We studied frequency of allergic IH among ICM or GBCM reactors.
Methods: Patients were recruited in 31 hospitals between 2005 and 2009. Clinical symptoms, plasma histamine and tryptase concentrations and skin tests were recorded. Allergic IH was diagnosed by intradermal tests (IDT) with the culprit CM diluted 1:10, "potentially allergic" IH by positive IDT with pure CM, and non-allergic IH by negative IDT.
Findings: Among 245 skin-tested patients (ICM = 209; GBCM = 36), allergic IH to ICM was identified in 41 (19.6%) and to GBCM in 10 (27.8%). Skin cross-reactivity was observed in 11 patients with ICM (26.8%) and 5 with GBCM (50%). Allergy frequency increased with clinical severity and histamine and tryptase concentrations (p < 0.0001). Cardiovascular signs were strongly associated with allergy. Non-allergic IH was observed in 152 patients (62%) (ICM:134; GBCM:18). Severity grade was lower (p < 0.0001) and reaction delay longer (11.6 vs 5.6 min; p < 0.001). Potentially allergic IH was diagnosed in 42 patients (17.1%) (ICM:34; GBCM:8). The delay, severity grade, and mediator release were intermediate between the two other groups.
Interpretation: Allergic IH accounted for < 10% of cutaneous reactions, and > 50% of life-threatening ones. GBCM and ICM triggered comparable IH reactions in frequency and severity. Cross-reactivity was frequent, especially for GBCM. We propose considering skin testing with pure contrast agent, as it is more sensitive than the usual 1:10 dilution criteria.
Figures



References
-
- Johansson S.G.O., Bieber T., Dahl R. Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J Allergy Clin Immunol. 2004;113:832–836. - PubMed
-
- Lasser E.C., Lyon S.G., Berry C.C. Reports on contrast media reactions: analysis of data from reports to the U.S. Food and Drug Administration. Radiology. 1997;203:605–610. - PubMed
-
- Katayama H., Yamaguchi K., Kozuka T., Takashima T., Seez P., Matsuura K. Adverse reactions to ionic and nonionic contrast media. A report from the Japanese Committee on the Safety of Contrast Media. Radiology. 1990;175:621–628. - PubMed
-
- Lieberman P.L., Seigle R.L. Reactions to radiocontrast material. Anaphylactoid events in radiology. Clin Rev Allergy Immunol. 1999;17:469–496. - PubMed
-
- Prince M.R., Zhang H., Zou Z., Staron R.B., Brill P.W. Incidence of immediate gadolinium contrast media reactions. AJR Am J Roentgenol. 2011;196:W138–W143. - PubMed
LinkOut - more resources
Full Text Sources